NCT00003541
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,052 public trials
2,037 recruiting studies
Lymphoproliferative Disorders trial results
NCT00003150
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- MBCCOP - Gulf Coast Mobile, Alabama, United States
- CCOP - Greater Phoenix Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
NCT00004057
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00003149
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Indiana University Cancer Center Indianapolis, Indiana, United States
- Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis, Indiana, United States
- CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
- CCOP - Ochsner New Orleans, Louisiana, United States
Completed
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT00006008
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
- Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
- Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
- Stanford University Medical Center Stanford, California, United States
NCT00737516
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- StemCyte International Cord Blood Center Covina, California, United States
- Children's Hospital of Orange County Cord Blood Bank Orange, California, United States
- Ashley Ross Cord Blood Program San Diego, California, United States
- University of Colorado Cord Blood Bank Aurora, Colorado, United States
Completed
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
NCT00520494
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Bruton type agammaglobulinemia, +10 more
- Locations
-
- Contact CSL Behring for facility details Edmonton, Alberta, Canada
- Contact CSL Behring for facility details Montreal, Quebec, Canada
- Contact CSL Behring for facility details Leipzig, Germany
- Contact CSL Behring for facility details Brescia, Italy
NCT00002471
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +22 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Kaplan Cancer Center New York, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
NCT00217503
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
NCT00019227
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States